Yasui‐Furukori, N., Muraoka, H., Hasegawa, N., Ochi, S., Numata, S., Hori, H., Hishimoto, A., Onitsuka, T., Ohi, K., Hashimoto, N., Nagasawa, T., Takaesu, Y., Inagaki, T., Tagata, H., Tsuboi, T., Kubota, C., Furihata, R., Iga, J., Iida, H., Miura, K., Matsumoto, J., Yamada, H., Watanabe, K., Inada, K., Shimoda, K., & Hashimoto, R. (2022). association between the examination rate of treatment‐resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study. Neuropsychopharmacology reports, 42(1), 3–9. http://access.bl.uk/ark:/81055/vdc_100152641782.0x000002